Are you Dr. Woronow?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 65 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
12609 Celtic CT
Rockville, MD 20850Phone+1 301-367-3856- Is this information wrong?
Summary
- Dr. Daniel Woronow, MD is a cardiologist in Rockville, Maryland. He is currently licensed to practice medicine in Maryland, Tennessee, and Florida. He is affiliated with Holy Cross Hospital, Adventist HealthCare Rehabilitation, and MedStar Washington Hospital Center.
Education & Training
- Brown UniversityFellowship, Cardiovascular Disease, 1981 - 1983
- University of MarylandResidency, Internal Medicine, 1978 - 1981
- Johns Hopkins University School of MedicineClass of 1978
Certifications & Licensure
- FL State Medical License 1993 - 2025
- MD State Medical License 1979 - 2025
- DC State Medical License 1983 - 2022
- TN State Medical License 2013 - 2015
- OK State Medical License 1987 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2011
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 2 citationsValsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study.Efe Eworuke, Mayura Shinde, Laura Hou, Michael J Paterson, Peter Bjødstrup Jensen, Judith C Maro, Ashish Rai, Daniel Scarnecchia, Dinci Pennap, Daniel Woronow, Rebecca...> ;BMJ Open. 2023 Apr 17
- 6 citationsAcute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration.Daniel Woronow, Christine Chamberlain, Ali Niak, Mark Avigan, Monika Houstoun, Cindy Kortepeter> ;JAMA Internal Medicine. 2022 Oct 1
- Abiraterone acetate-associated QT prolongation and torsades de pointes: Postmarketing cases reported to FDA.Lauren McBride, Daniel Woronow, Afrouz Nayernama, S. Christopher Jones> ;Journal of Oncology Pharmacy Practice. 2021 May 14
- Join now to see all
Press Mentions
- FDA Data Link Diabetes Drug Class to Gallbladder DiseaseAugust 30th, 2022
Professional Memberships
- Member
Hospital Affiliations
- MedStar Washington Hospital CenterWashington, District of Columbia
- University of Maryland Baltimore Washington Medical CenterGlen Burnie, Maryland
- Holy Cross HospitalSilver Spring, Maryland
- Adventist HealthCare RehabilitationTakoma Park, Maryland